These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21297108)

  • 1. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure.
    Pang W; Wang RR; Gao YD; Yang LM; Sun Y; Huang JF; Tien P; Zheng YT
    J Biomol Screen; 2011 Feb; 16(2):221-9. PubMed ID: 21297108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41.
    Liu S; Boyer-Chatenet L; Lu H; Jiang S
    J Biomol Screen; 2003 Dec; 8(6):685-93. PubMed ID: 14711394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41.
    Jin BS; Lee WK; Ahn K; Lee MK; Yu YG
    J Biomol Screen; 2005 Feb; 10(1):13-9. PubMed ID: 15695339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M
    Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mammalian two-hybrid system-based assay for small-molecular HIV fusion inhibitors targeting gp41.
    Shui X; Lu X; Gao Y; Liu C; Ren F; Jiang Q; Zhang H; Zhao B; Zheng Z
    Antiviral Res; 2011 Apr; 90(1):54-63. PubMed ID: 21352856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
    Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
    Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies.
    Mzoughi O; Gaston F; Granados GC; Lakhdar-Ghazal F; Giralt E; Bahraoui E
    ChemMedChem; 2010 Nov; 5(11):1907-18. PubMed ID: 20922745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD
    AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41.
    Gallo SA; Clore GM; Louis JM; Bewley CA; Blumenthal R
    Biochemistry; 2004 Jun; 43(25):8230-3. PubMed ID: 15209519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
    J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1.
    Debnath AK; Radigan L; Jiang S
    J Med Chem; 1999 Aug; 42(17):3203-9. PubMed ID: 10464007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A time-resolved fluorescence assay to identify small-molecule inhibitors of HIV-1 fusion.
    Dams G; Van Acker K; Gustin E; Vereycken I; Bunkens L; Holemans P; Smeulders L; Clayton R; Ohagen A; Hertogs K
    J Biomol Screen; 2007 Sep; 12(6):865-74. PubMed ID: 17644771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket.
    Bai Y; Xue H; Wang K; Cai L; Qiu J; Bi S; Lai L; Cheng M; Liu S; Liu K
    Amino Acids; 2013 Feb; 44(2):701-13. PubMed ID: 22961335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.
    Ferrer M; Kapoor TM; Strassmaier T; Weissenhorn W; Skehel JJ; Oprian D; Schreiber SL; Wiley DC; Harrison SC
    Nat Struct Biol; 1999 Oct; 6(10):953-60. PubMed ID: 10504731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a FRET assay for monitoring of HIV gp41 core disruption.
    Xu Y; Hixon MS; Dawson PE; Janda KD
    J Org Chem; 2007 Aug; 72(18):6700-7. PubMed ID: 17685571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.
    Jiang S; Lu H; Liu S; Zhao Q; He Y; Debnath AK
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4349-59. PubMed ID: 15504864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [1,2,6-tri-O-galloyl-beta-D-glucopyranose inhibits gp41-mediated HIV envelope fusion with target cell membrane].
    Sun W; Wang HT; Xia CL; Wu SG; Jiang SB; Jiang ZH; Liu SW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1127-31. PubMed ID: 18676243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homogeneous time-resolved fluorescence assay to identify inhibitors of HIV-1 fusion.
    Smeulders L; Bunkens L; Vereycken I; Van Acker K; Holemans P; Gustin E; Van Loock M; Dams G
    Methods Mol Biol; 2013; 1030():11-7. PubMed ID: 23821256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41.
    Fuhrman CA; Warren AD; Waring AJ; Dutz SM; Sharma S; Lehrer RI; Cole AL; Cole AM
    FEBS J; 2007 Dec; 274(24):6477-87. PubMed ID: 18028423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.